Premier, Inc. (PINC)
NASDAQ: PINC · Real-Time Price · USD
27.86
-0.04 (-0.14%)
At close: Oct 6, 2025, 4:00 PM EDT
27.86
0.00 (0.00%)
After-hours: Oct 6, 2025, 4:00 PM EDT
Premier Revenue
In the fiscal year ending June 30, 2025, Premier had annual revenue of $1.01B, down -10.86%. Premier had revenue of $262.86M in the quarter ending June 30, 2025, a decrease of -12.45%.
Revenue (ttm)
$1.01B
Revenue Growth
-10.86%
P/S Ratio
2.51
Revenue / Employee
$375,054
Employees
2,700
Market Cap
2.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.01B | -123.36M | -10.86% |
| Jun 30, 2024 | 1.14B | 40.67M | 3.71% |
| Jun 30, 2023 | 1.10B | -337.56M | -23.56% |
| Jun 30, 2022 | 1.43B | -288.25M | -16.75% |
| Jun 30, 2021 | 1.72B | 421.56M | 32.44% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PINC News
- 12 days ago - PREMIER INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Premier, Inc. - PINC - Business Wire
- 14 days ago - Patient Square Capital to Buy Premier Inc. in $2.6 Billion Deal - WSJ
- 14 days ago - Premier, Inc. Announces Definitive Agreement to Be Acquired by Patient Square Capital in Transaction Valued at $2.6 Billion - Business Wire
- 19 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 20 days ago - Premier Infusion and Healthcare Services, Inc. (Premier Infusion and HCS) Selects Premier, Inc. as Its GPO Partner to Power Ambulatory Infusion Growth - Business Wire
- 27 days ago - Premier, Inc. Appoints Bruce Radcliff as President of Supply Chain Services - Business Wire
- 4 weeks ago - Premier, Inc. to Participate in Baird Global Healthcare Conference on September 9, 2025 - Business Wire
- 6 weeks ago - Premier Analysts Increase Their Forecasts Following Better-Than-Expected Results - Benzinga